Gilead Sciences, Inc.

Array Biopharma Inc.

Microsoft Technology Licensing, LLC

The Allen Institute for Artificial Intelligence

Boston Scientific Scimed, Inc.

Christopher T Clark

Kirk L Stevens

Kevin S Currie

Peter A Blomgren

Jeffrey E Kropf

Laurence Edward Burgess

Zhongdong Zhao

Leena Patel

Kevin W Hunt

Jayaraman Chandrasekhar

Yasamin Moazami

Jason K Perry

Taryn Campbell

Natalie Seeger

Nicole Nava

John O Link

James G Taylor

William John Watkins

Gary Bruce Phillips

Jeromy J Cottell

George A Doherty

Elizabeth M Bacon

Sheila M Zipfel

Jennifer Anne Treiberg

Thorsten A Kirschberg

Scott D Schroeder

Adam Wade Cook

Nathan E Wright

Musong Kim

Suet Chung Yeung

Julian Andrew Codelli

Neil H Squires

Stephane Perreault

Christopher Peter Corrette

Gayatri Balan

Chien-Hung Chou

Ganghyeok Kim

Kassandra F Sedillo

Todd T Romoff

Jesse Clay Satterfield

Feng Zhao

Jensen Michael Harris

Sashi Raghupathy

Manoj Kumar Biswas

Ahsan Syed Kabir

Ginger J Gloystein

Robert Kirk Delisle

Katie Messerly

Billie Sue Chafins

Devang Thakker

Olivier Tritschler

Patrik Lundberg

Robert Kirk DeLisle

Christopher P Corrette

James P Rizzi

Mark C Munson

Petr Jansa

Brian Joseph Tischler

Joshua A Kaplan

Jennifer R Lo

Daniel H Byun

Mark McPhail

Zachary A Kasun

Luke Zettlemoyer

Megan E Neubig

Nathaniel H Stanley

James L Bachman

Mark Neumann

Kenton Lee

Matt Gardner

Mohit Iyyer

Matthew E Peters

Ahsan Kabir

Mark Mcphail

Compounds of formula: wherein the variable substituents are defined herein.

KHK inhibitors

The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.

Quinoline derivatives

The present disclosure relates generally to modulators of Cot (cancer Osaka thyroid) and methods of use and manufacture thereof.

Cot modulators and methods of use thereof

The present disclosure provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), therapeutic methods for treating inflammatory disease.

Compounds for inhibition of &#x3b1;4 &#x3b2;7 integrin

Compounds for inhibition of alpha 4 beta 7 integrin

Compounds for inhibition of &#x3b1;4&#x3b2;7 integrin

Imidazopyridine derivatives

Systems, apparatuses, and methods for representing words or phrases, and using the representation to perform NLP and NLU tasks, where these tasks include sentiment analysis, question answering, and conference resolution. Embodiments introduce a type of deep contextualized word representation that models both complex characteristics of word use, and how these uses vary across linguistic contexts. The word vectors are learned functions of the internal states of a deep bidirectional language model (biLM), which is pre-trained on a large text corpus. These representations can be added to existing task models and significantly improve the state of the art across challenging NLP problems, including question answering, textual entailment and sentiment analysis.

System and methods for performing NLP related tasks using contextualized word representations

An operating system provides an extensible share action to broker content sharing between applications executing on a computing platform such as a personal computer, tablet computer, or smartphone. The share action enables a consistent user experience for content sharing to be implemented across all applications and eliminates users having to switch from the current application they are using to some other functionality in order to share content. Applications can participate with the operating system share action as source applications and/or target applications. Source applications may describe what content is shareable given the current state of their application when the user chooses to invoke the share action. Target applications can be configured to receive the shared content from the source application according to content type, and will expose a companion view of their application to the user that is specifically tailored to facilitate sharing.

Extensible system action for sharing while remaining in context

COT modulators and methods of use thereof

Growing community of inventors

Seattle, WA, United States of America

Christopher T Clark